Aroa Biosurgery (ASX:ARX)
ASX announcement history & article coverage
Transparent by design.
Announcments by Aroa Biosurgery (ASX:ARX) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Resignation of CFO and Joint Company Secretary
Appendix 4G and Corporate Governance Statement
Annual Report to Shareholders
Aroa Biosurgery reports 23% revenue growth, positive EBITDA, and strong FY27 guidance
Change of Director's Interest Notice - JD
Notice of AGM Date and Director Nomination Closing Date
Change in substantial holding
FY26 Full Year Results Presentation - Correction
Aroa Biosurgery corrects FY26 presentation typo; reports strong FY26 results exceeding guidance with robust growth and positive FY27 outlook
FY26 Full Year Results Presentation
Aroa Biosurgery FY26 revenue NZ$104m beats guidance; EBITDA NZ$13m; Myriad sales +54%; Symphony RCT success
FY26 Appendix 4E and Full Year Results
Aroa Biosurgery FY26 revenue up 23%, EBITDA triples; FY27 guidance signals continued growth and investment
Notification of Full Year Results Webinar
Aroa Biosurgery to host webinar on FY2026 audited results on 26 May 2026
ARX FY26 Preliminary Results
Aroa Biosurgery FY26 preliminary results exceed revenue and EBITDA guidance with strong Myriad portfolio growth